Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anke Graessel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2022
Ameliorating Atopy by Compensating Micronutritional Deficiencies in Immune Cells: A Double-Blind Placebo-Controlled Pilot StudyTina Bartosik, Sebastian A Jensen, Sheriene M Afify, et al.
Allergy|July 18, 2025
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based ApproachOliver Pfaar, Ralph Mösges, Michael S Blaiss, et al.
The World Allergy Organization Journal|October 18, 2021
Dogmas, challenges, and promises in phase III allergen immunotherapy studiesPieter-Jan De Kam, Matthias F Kramer, Mohamed H Shamji, et al.
Allergy|May 10, 2019
Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic DiseasesIoana Agache, Isabella Annesi-Maesano, Andreas Bonertz, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2022
Ameliorating Atopy by Compensating Micronutritional Deficiencies in Immune Cells: A Double-Blind Placebo-Controlled Pilot StudyTina Bartosik, Sebastian A Jensen, Sheriene M Afify, et al.
Allergy|July 18, 2025
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based ApproachOliver Pfaar, Ralph Mösges, Michael S Blaiss, et al.
The World Allergy Organization Journal|October 18, 2021
Dogmas, challenges, and promises in phase III allergen immunotherapy studiesPieter-Jan De Kam, Matthias F Kramer, Mohamed H Shamji, et al.
Allergy|May 10, 2019
Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic DiseasesIoana Agache, Isabella Annesi-Maesano, Andreas Bonertz, et al.
Pageof 2